The right pediatric program to deliver your medicine sooner.
Let expertise be your guide
Successfully navigating the road to developing and delivering pediatric products requires a specialized mix of scientific, therapeutic, regulatory and operational expertise to ensure your pediatric studies are successfully planned and executed.
从临床开发的最早计划阶段，通过推出和现实世界的评估，小儿专业知识是确保您提出正确的问题以满足婴儿，儿童和青少年的特定需求的关键。
364 pediatric studies
在2013年至2018年之间在101个国家 /地区进行
从头到尾，我们都在这里
在IQVIA，我们准备在您的整个旅程中提供量身定制的知情支持。我们可以提供帮助
- 制定产品的儿科调查计划（PIP）和/或儿科研究计划（PSP）
- 通过使用建模，仿真和现实世界数据推荐替代研究设计
- Navigate complex and unique regulatory requirements for pediatric clinical research
- 将您连接到专业的儿科研究网站网络
- Identify, consent/assent and retain pediatric patients and their families throughout your program
Pediatric Center of Excellence
Experts from across IQVIA come together to help you conceptualize and execute your pediatric studies. The group is charged with advising on the conduct of pediatric programs to ensure the right strategy and the right level of oversight, counsel, training and collaboration is applied to your project. Identify the right path to fulfill pediatric safety requirements and deliver a product that meets the unique needs of infants, children and adolescents, from trial environments into their everyday lives.
Advancing Pediatric Cancer Research
The RACE for Children Act will have significant impact on cancer drug development. Among all ongoing cancer trials, more than 70% involve RACE-defined molecular target drugs, but only 6.9% appear to include pediatric-age participants, according to a new analysis conducted by the IQVIA Institute.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Richer real world data insights can drive smarter decisions.
直接向患者带来试验，以改善访问和参与度，提高质量并缩短时间表。